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Abstract. Microtubules (MTs) in the axon have a uni-
form polarity orientation that is recapitulated dur-
ing recovery from episodes of MT depolymerization
(Heidemann, S. R., M . A. Hamborg, S. J. Thomas,
B. Song, S. Lindley, and D. Chu. 1984. J. Cell Biol.
99:1289-1295). This tight regulation of their organiza-
tion indicates that axonal MTs are spatially regulated
by discrete nucleating structures comparable in func-
tion to the centrosome. Several authors have proposed
that an especially stable class of MTs in the axon may
serve as these nucleating structures. In a previous re-
port (Baas, P W., and M. M . Black. 1990. J. Cell
Biol. 111:495-509), we determined that the axons of
cultured sympathetic neurons contain two classes of
MT polymer, stable and labile, that differ in their sen-
sitivity to nocodazole by roughly 35-fold. The stable
and labile polymer represent long-lived and recently
assembled polymer, respectively. We also determined
that these two classes of polymer can be visually dis-
tinguished at the immunoelectron microscopic level
based on their content of tyrosinated ci-tubulin: the la-
bile polymer stains densely, while the stable polymer
T
HE organization of microtubules (MTs)' in the axon
is tightly regulated. The plus ends of the MTs are uni-
formly oriented away from the cell body, toward the
axon tip (Heidemann et al., 1981; Burton and Paige, 1981;
Baas et al., 1987, 1988, 1989, 1991b) . Moreover, this organi-
zation is recapitulated during recovery from episodes ofMT
depolymerization (Heidemann et al ., 1984; Baas et al.,
1987). Theseobservations indicate that highlyefficient mech-
anisms exist within the axon to ensure that all MTs are as-
sembled with a plus-end-distal orientation. Because the plus
end of the MT is, by definition, the end preferred for as-
sembly (Binder et al., 1975; Bergen and Borisy, 1980), such
an organization is likely to have important implications for
the manner by which the MT array ofthe axon is elaborated.
In addition, because different organelles appear to be prefer-
entially translocated toward either the plus or the minus end
of the MT, the polarity orientation of MTs in the axon will,
1. Abbreviation used in this paper: MT, microtubule.
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does not stain. In the present study, we have taken ad-
vantage of these observations to directly identify MT
nucleating structures in the axon. Neuron cultures
were treated with nocodazole for 6 h to completely
depolymerize the labile polymer in the axon, and sub-
stantially shorten the stable polymer. The cultures
were then rinsed free of the drug, permitted to reas-
semble polymer for various periods of time, and pre-
pared for immunoelectron microscopic localization of
tyrosinated ci-tubulin. Serial reconstruction of consec-
utive thin sections was undertaken to determine the
spatial relationship between the stable MTs and the
newly assembled polymer. All of the new polymer as-
sembled in direct continuity with the plus ends of stable
MTs, indicating that these ends are assembly compe-
tent, and hence capable of acting as nucleating struc-
tures. Our results further indicate that no self-assembly
of MTs occurs in the axon, nor do any MT nucleating
structures exist in the axon other than the plus ends of
stable MTs. Thus the plus ends of stable MTs are the
exclusive nucleating structures for MTs in the axon.
in part, determine its cytoplasmic composition (Baas et al.,
1988; Black and Baas, 1989). Although these observations
clearly indicate an essential role for MT organization in de-
fining the cytoarchitecture of the axon, surprisingly little is
known about the mechanisms by which this organization is
established and maintained.
Most information on MT assembly and organization has
derived from in vitro studies, or from studies on non-
neuronal cells. In the test tube, MT assembly can occur by
self-association oftubulin subunits, but preferentially occurs
by elongation from a MT template or nucleating structure
(for review see Kirschner, 1978). Studies on MT assembly
in intact cells indicate that self-association is strongly sup-
pressed in favor of nucleated assembly, and that MT nuclea-
tion is spatially regulated by discrete nucleating structures
such as the centrosome (for review see Brinkley, 1985) . The
minus ends of the MTs are embedded within the nucleating
structure, whilethe plus ends radiate away from it, resulting
in MT arrays of uniform polarity orientation (Haimo et al.,
12311979; Heidemann and McIntosh, 1980; Euteneuer and
McIntosh, 1981) . The uniform polarity orientation ofaxonal
MTs suggests that they too may be spatially regulated by
nucleating structures. However, the identity of these putative
nucleating structures has been elusive. In fact, it is now well
established that MTs in the axon do not emanate from a com-
mon centralized structure such as the centrosome (Lyser,
1968; Sharp et al., 1982) . Instead, they appear to stop and
start at multiple sites along the length of the axon, with no
apparent specializations at their minus ends which could
serve as nucleating structures (Bray and Bunge, 1981; Tsu-
kita and Ishikawa, 1981).
An intriguing hypothesis, suggested by several authors, is
that a unique class of especially stable MTs may act as the
MT nucleating structures in the axon (Morris and Lasek,
1984; Brady et al., 1984; Black et al., 1984; Heidemann et
al., 1984; Baas and Heidemann, 1986 ; Sahenk and Brady,
1987) . A key prediction of this hypothesis is that individual
MTs in the axon will consist ofa stable domain in direct con-
tinuity with a newly assembled, more labile domain. In a re-
cent study, we were able to test this prediction using immu-
noelectron microscopy to visually distinguish stable and
labile MT polymer in the axons of cultured sympathetic neu-
rons (Baas and Black, 1990). We reported that roughly half
the MT mass in these axons is labile, depolymerizing with
a halftime of - 3.5 min in the presence of 2 l.g/ml nocoda-
zole, whilethe other half is relatively stable, depolymerizing
with a halftime of -130 min (see also Baas et al., 1991b).
Staining for tyrosinated a-tubulin distinguishes the labile
polymer from the stable polymer: the former is rich in tyrosi-
nated a-tubulin, while the latter is deficient in this a-tubulin
variant. In our immunoelectron micrographs, a significant
proportion of the MT profiles showed stable polymer in di-
rect continuity with labile polymer. In all such cases, the la-
bile domain of the MT was situated at the plus end of the
stable domain (see Baas and Black, 1990 for more details) .
These observations provide strong support forthe hypothesis
that stable MTs serve as MT nucleating structures in the
axon, and further suggest that it is specifically the plus ends
of the stable MTs from which new assembly occurs.
In the present study, we have sought to directly test these
hypotheses by determining the distribution and identity of
the MT nucleating structures in the axon. To accomplish
these goals, we used a strategy similar to that which has been
used previously to identify MT nucleating structures in non-
neuronal cells (De Brabander et al., 1977, 1980; Brinkley,
1985 ; Gunderson et al., 1987; Bulinski et al., 1988) . Neuron
cultures were treated with nocodazole for a time sufficient
to completely depolymerize the labile MT polymer in the
axon. The drug was then rinsed from the cultures, and they
were permitted brief periods of MT reassembly. To deter-
mine the distribution of MT nucleating structures in the
axon, newly assembled polymer was visualized by im-
munofluorescence staining for tyrosinated a-tubulin along
the length of the axon. To determine the identity of the
nucleating structures, newly assembled polymer was visual-
ized by immunoelectron microscopy, and its relationship
with the stable polymer, or other potential nucleating struc-
tures, was determined by serial reconstruction of consecu-
tive thin sections. The results of these studies were conclu-
sive: all new assembly occurred specifically from the plus
ends of stable MTs, which were distributed throughout the
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length of the axon. No assembly occurred from the minus
ends, nor did any assembly occur independently ofthe stable
MTs. These observations indicate that the plus ends of stable
MTs are assembly competent, and are the exclusive MT
nucleating structures in the axon.
Materials andMethods
Cell Culture
Sympathetic neurons from the superiorcervical ganglia ofnewborn ratpups
were cultured in two ways. Dissociated cultures were used for im-
munofluorescence analyses because they permit visualization along sub-
stantial lengths (hundreds of micrometers) ofindividual axons. Explantcul-
tures were used for electron microscopic analyses because they maximize
thenumber of aligned axons, and henceMTs ofknownpolarity orientation,
that can be sectioned simultaneously. Methods for the preparation ofthese
cultures were as previously described (Baas and Black, 1990), except that
dissociated cultures were grownatparticularly low density to limit dendritic
outgrowth (see Higgins et al., 1991). Fig. 1, a and b, shows phase-contrast
micrographs of a dissociated and explant culture, respectively.
Nocodazole Reatments
Nocodazole, a potent anti-MT drug, was purchased from Aldrich Chemical
Co. (Milwaukee, WI). A stock solution of5 mg/ml was prepared in DMSO,
and diluted intissue culture mediumat 1:2,500 or 1:500 for final concentra-
tions of 2 and 10 14g/ml, respectively. Both the stock solution and the
drugged medium were prepared fresh for each experiment, and fresh
nocodazole was purchased each month. Nocodazole-containing medium
was warmed to 37°C and applied to the cells for either 1 or 6 h, depending
on the experiment. For recovery, cultures were rinsed twice briefly with
drug-free tissue culture medium and then incubated for the designated
recovery time in a third rinse of drug-free medium at 37°C. Tuning for
recovery began at the point at which the third rinse of drug-free medium
was added, and recovery times ranged from i min to 24 h. Previous studies
have determined that nocodazole is immediately and completely reversible
when rinsed from neuron cultures in this manner, even when the drug is
used at higher concentrations than those used here (Baas and Heidemann,
1986).
ImmunologicalProcedures
Immunofluorescence and immunoelectron microscopic analyses were per-
formed as previously described (Bees and Black, 1990). Briefly, cultures
were extracted in the presence of a MT stabilizing buffer to remove free
tubulin, and then fixed with cold (-20°C) methanol for immunofluores-
cence, or glutaraldehyde for inununoelectron microscopy. For inmmunoflu-
orescence, dissociated cultures were double labeled with YL 1/2 (Accurate
Chemical and Scientific Corp., Westbury, NY), a rat mAb which recog-
nizes the tyrosinated but notthe detyrosinated form of«-tubulin (Kilmartin
et al., 1982; Wehland et al., 1983), and a mousegeneral ß-tubulin antibody
purchased from Amersham Corp. (Arlington Heights, IL). These antibod-
ies were used atconcentrationsof 1:100and 1:300, respectively. TheYL 1/2
was visualized with a fluorescein-conjugated goat anti-rat second antibody,
and the ß-tubulinantibody was visualized with a Texas red-conjugated goat
anti-mouse second antibody. Both of these second antibodies were pur-
chased from Accurate Chemical and Scientific Corp., and usedat 1:100. For
immunoelectron microscopy, explant cultures were labeled with YL 1/2,
used ataconcentration of 1:200. The second antibody was the Janssen 5-nm
colloidal gold-conjugated goat anti-rat second antibody, purchased from
Amersham Corp., and used at 1:2.
Serial ReconstructionofAxonalMT§
Inununoelectron microscopic localization of tyrosinated a-tubulin distin-
guishes the stable MT polymer in the axon from the more recently assem-
bled polymer (Bass and Black, 1990).1b determine the spatial relationship
between these two types ofpolymer, we undertook serial reconstruction of
consecutive thin sections using a modification of our previously described
method (Bass and Heidemann, 1986; Joshi et al., 1986). In the original
method, the MT profilesfromconsecutive sectionsare traced ontotranspar-
ent plastic sheets, together with the cell membrane and internal membra-
1232nous elements. Consecutive sections are aligned usingthe membranous ele-
ments as registration markers. This results in an accurate alignment ofthe
MT profiles, revealing which profiles are actuallyportions ofthe sameMT.
Unfortunately, in the present study, it was necessary to extract the neurons
under very harsh conditions for the immunoelectron microscopic proce-
dure, resulting in the removal of virtually all membranous borders that
would otherwise have served as registration markers . Therefore, it was
necessary to developan alternative technique forthe alignment of consecu-
tive sections .
In the present technique, individual MTs were reconstructed one at a
time . Particularly small blockfaces (-0.75 x 0.1 mm) were carved from
the axonal regions of explant cultures such that a chain of 15 consecutive
serial sections could be picked up on a single butvar-coated slot grid. Next,
the observation screen on an electron microscope (model CX100 ; JEOL
U .S.A . Inc., Peabody, MA) was removed from the instrument, and a mesh-
work consisting of2-mm squares was drawn on thescreen with a sharp lead
pencil, after whichthe screen was returned to the electron microscope. For
ease of relocation, regions of the sections destined for serial reconstruction
were first selected by their proximity to one ofthe four comers ofthe sec-
tion . Then, a singleMT profile was selected from the middle section ofthe
series (the 8th section of 15), and its precise location, length, and shape
within the meshwork weredrawn onto a corresponding map. The map con-
tained a meshwork identical to that on the screen, and at the magnification
used on the electron microscope, distances as little as the diameterof a sin-
gleMT (24 run) could be accurately discerned and translated onto the map.
Also recorded on the map were any residual bits of cellular material or de-
bris that could serve as registration markers to align the nextsection . Using
this system, theMT ofinterest was followed out in both directions, andMT
profiles continuous with the originalprofile were drawn ontothe map . Once
all 15 sections were examined, theMT was considered as a data point only
if both ends of the MT terminated within the 15 sections. Otherwise, the
MT was discarded as uninterpretable for our purposes . Regions oftheMT
that were labeled or unlabeled with gold particles were also recorded on
the map.
MTPolarity Determination
Tb determine the polarity orientation ofMD in control, drug-treated, and
drug-recovered neuron cultures, we used the standard "hooking" protocol
(Heidemann and McIntosh, 1980; Baas et al ., 1989; for review see
Heidemann, 1991) . In this procedure, cultures are lysed in the presence of
a special MTassembly buffer containing exogenous brain tubulin, and then
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prepared forEM by conventional means . The exogenous tubulin adds onto
existing MTs inthe form oflateral sheets that appear as "hooks" onthe MTs
when viewed incross section. The curvature of the hookreveals thepolarity
orientation of the MT; a clockwise hook indicates that the plus end of the
MT is directed toward the observer, while a counterclockwise hook indi-
catesthe opposite . In the present study, control and experimentally manipu-
lated explant cultures were rinsed in PBS and then treated for 30 min at
37°C with 0.06% Brij 58 in a MT assembly buffer (0.5 M Pipes, 0.1 mM
EGTA, 0 .01 mM EDTA, 0.1 mM MgC12, 2.5% DMSO, 0.5 mM GTP)
containing 1.2 mg/ml MT protein . Cultures were fixed by the addition of
an equal quantity of 4% glutaraldehyde . After preparation and embedment
for EM, cross sections ofthe axons were taken, and hooks were interpreted
and scored as previously described (Heidemann and McIntosh, 1980;
Heidemann, 1991) . As in our previous work, hooks werejudged as clock-
wise or counterclockwise from the vantage point of the growth cone .
Results
Distribution ofMTNucleating Structures in theAxon
The strategy of the present studies was to visualize MT
nucleating structures in the axon by their capacity to initiate
the reassembly of MTs during recovery from nocodazole
treatment. To determine the distribution of these nucleating
structures, immunofluorescence microscopy was used to
visualize newly assembled polymer along the length of the
axon . Because the stable MT polymer within the axon is a
candidate for the MT nucleating structures, and because
shortening the stable polymer would alter the distribution of
its ends, it was necessary for these studies to choose a drug
treatmentthat would completely depolymerize the labile poly-
mer without substantially shortening the stable polymer.
Our previous determinations for the halftimes of depolymer-
ization of the stable and labile polymer in the presence of 2
lAg/ml nocodazole indicate that 1 h of drug treatment at this
concentration depolymerizes virtually 100% of the labile
polymer, but <20% ofthe stable polymer (Baas and Black,
1233
Figure 1. Phase-contrast micrographs ofrat sym-
pathetic neurons grown in two different ways
for the present study . a shows a dissociated neu-
ron culture, the type used for immunofluores-
cence analyses, while b shows an explant cul-
ture, the type used for electron microscopic
analyses . See Materials and Methods for more
details . Bar : (a) 100 Am ; (b) 200 um .Figure 2 . Double-label immunofluorescence analyses onthe axons ofcultured sympathetic neurons. TheYL 1/2 antibody against tyrosinated
a-tubulin was used to localize newly assembledMT polymer in the axon (a, c, e, and g), and a general 0-tubuln antibody was used to
visualize total polymer (b, d, f, and h) . a and b are control axons; c andd are axons from cultures treated with 2 Ag/ml nocodazole for
1 h; e andfare axons recovered from such nocodazole treatment for 5 min ; and g and h are axons recovered for 30 min . Staining for
both antibodies is present throughout the length ofcontrol axons. Staining for tyrosinated polymer, but not total polymer, is virtually elimi-
nated after nocodazole treatment . During recovery, newpolymer assembles in discrete segments that are apparent along the axons length
at 5 minof recovery (area between arrows is unstained for tyrosinated tubulin but stains for total tubulin indicating the presence of stable
but not new polymer in this region) . By 30 minof recovery, axons once again stain along their lengths for new as well as total polymer.
Bar, 20 ,,m .
1990 ; Baas et al ., 1991b; seeintroduction) . After such treat-
ment, nocodazole was rinsed from the cultures, and periods
of recovery ranging from 1 min to 24 h were permitted . If
MT assembly in the axon is regulated by nucleating struc-
tures, as indirect evidence suggests (see introduction), we
would predict that new assembly should appear in discrete
regionsof the axon . On the otherhand, if de novo initiation
of MT assembly occurs in the axon, we would expect rela-
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tively uniform levels of recovery to occur along the axon's
length .
The results of these experiments are shown in Fig. 2.
As described in Materials and Methods, the cultures were
double stained with an antibody for tyrosinated a-tubulin
to visualize the newly assembled polymer, and a general
ß-tubulin antibody to visualize total polymer. In control
axons, bothantibodies stain relatively evenly alongthelength
1234oftheaxon,indicating thatlabile polymer and probably stable
polymer are present throughout the axon (Fig. 2, a and b;
see also Baas and Black, 1990; Baas et al., 1991b). After
nocodazole treatment, the staining for tyrosinated a-tubulin
is diminished almost completely (Fig. 2 c), while the stain-
ing for the general tubulin antibody is somewhat dimmer, but
still relatively continuous along the length of the axon (Fig.
2 d) . The latter observation confirms the widespread distri-
bution ofstable polymer alongthe axon's length. After 1 min
of recovery from nocodazole, discrete segments of staining
for tyrosinated a-tubulin begin to become apparent, but are
difficult to capture in a photograph (not shown) . After 5 min
of recovery, the segments are more dramatic, and are mani-
fest as 20-100-,um stretches of relatively bright staining
flanked by unstained or more dimly stained regions of some-
what shorter lengths (5-50 wm; Fig. 2 e) . After 10 min of
recovery, the stained regions are significantly longer, such
that only infrequent unstained regions can be seen (not
shown). By 30 min, staining for tyrosinated a-tubulin is con-
tinuous alongthe axon's length (Fig. 2 g). Correspondingly,
staining for the general tubulin antibody becomes more in-
tense with increasing recovery times (Fig. 2,fand h). These
observations are consistent with the hypothesis that MT as-
sembly in the axon occurs from discrete nucleating struc-
tures, and indicate that these nucleating structures have a
widespread (but uneven) distribution throughout the length
of the axon.
A slight variation on these results was observed in the dis-
tal region ofthe axon contiguous with the growth cone. After
nocodazole treatment, this region (spanning -10-50 Jim
from the axon tip) showed no staining for either the antibody
against tyrosinated a-tubulin or the general tubulin antibody.
This result is consistent with our previous observation that
all of the MT polymer in this region is labile (Baas and
Black, 1990) . During recovery, this region always showed a
bright segment of staining for tyrosinated a-tubulin, which
appeared to extend from the mainshaftofthe axon where sta-
ble MTs are present. These data, not shown in figures, are
entirely similar to previous observations of this type on the
growth cone region of shorter axons (Arregui et al ., 1991).
These observations indicate that no MT nucleating struc-
tures are present in the distal region of the axon. Instead, the
nucleating structures for the distal axon are located more
proximally, in the axon's mainshaft .
Identification ofMT Nucleating Structures
in theAxon
To determine the identity of the MT nucleating structures in
the axon, nocodazole recovery experiments were performed
at the immunoelectron microscopic level. Our strategy was
to visualize newly assembled MT polymer by its staining for
tyrosinated a-tubulin, and then identify the structures from
which the new polymer elongates. Because the thin sections
required for EM contain only portions of individual MTs, it
was necessary to perform serial reconstructions of consecu-
tive thin sections to accurately determine the spatial relation-
ship between the new polymer and potential nucleating struc-
tures. In previous work, we serially reconstructed segments
of the axon, using membranous borders as registration mark-
ers to align the MT profiles in consecutive sections (Baas
and Heidemann, 1986; Joshi et al ., 1986) . For the present
work, this method was impossible because of the loss of
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membranous borders as a result of the extraction necessary
for immunogold labeling. Therefore, we developed an alter-
native technique that results in the reliable reconstruction of
individual MTs within serial sections ofextracted axons (see
Materials and Methods for details). Because the stable poly-
mer is a likely candidate for the nucleating structures, it was
necessary for these studies to capture both the plus and mi-
nus ends of the stable polymer, as well as both ends of the
new polymer. To ensure that a majority of the MTs in our
preparations were encompassed within the 15 sections that
were practical for use in this technique (see Materials and
Methods), we wished to minimize the length ofboth the sta-
ble and new polymer. To substantially shorten the stable
polymer, nocodazole treatment was extended to 6 h and the
concentration of the drug was increased to 10 ug/ml. This
treatment shortened the majority of MR to within a few
micrometers in length (see later in text). To determine the
recovery time that would be most practical for our serial
reconstructions, we assessed the levels of MT reassembly at
1, 5, and 30 min, and at 24 h of recovery.
For these initial studies, the total length of MT polymer
and the total length of polymer which did or did not label
for tyrosinated a-tubulin were measured in five randomly
selected spaces on our 200-mesh EM grids. The results of
these experiments are shown in Fig. 3, and the data are
presented graphically in Fig. 4. In presenting our data, the
levels of MT mass are all calculated as percentages relative
to total control levels. In control axons, roughly half the
polymer is labeled for tyrosinated a-tubulin, and roughly
half is unlabeled (Fig. 3a; see also Baas and Black, 1990;
Baas et al ., 1991b) . As in our previous studies, a small but
significant number of profiles show a labeled domain in di-
rect continuity with the plus end ofan unlabeled domain. Af-
ter nocodazole treatment, 5 % of the MT mass is remaining,
and all ofthis is unlabeled (Fig. 3 b) . The lengths ofindivid-
ual MT profiles captured in the nocodazole-treated axons
were also clearly shorter than those in control axons. After
1 min of recovery (Fig. 3 c), the levels ofunlabeled MT mass
were unchanged, but segments of labeled polymer were now
present. The levels of labeled polymer were equivalent to
5 % of the total MT mass in control axons. After 5 and 30
min (Fig. 3, d and e, respectively), unlabeled polymer still
showed no significant change, but labeled polymer had in-
creased to 17 and 90%, respectively. After 24 h of recovery
(Fig. 3f), the levels of MT mass and proportions of labeled
and unlabeled polymer are indistinguishable from those in
controls. At each point in recovery, a small number of pro-
files displayed labeled and unlabeled domains. As in the con-
trols, the labeled (i.e., newly assembled) domain was always
situated at the plus end of the unlabeled (i.e., stable) domain
(Fig. 3, c, e, andf). These results indicate a rapid reassembly
of polymer that approaches control levels after only -30
min, and a relatively slower rate of a-tubulin detyrosination
after assembly. In addition, these results provide initial data
favoring the hypothesis that new assembly occurs specifically
from the plus ends of stable polymer.
Assuming that MTs in the axons ofcultured neurons aver-
age -100 /.m in length (Brayand Bunge, 1981), these results
further indicate that 1 min of recovery is well suited for our
serial reconstruction studies. For these studies, two ap-
proaches were used. In one set of experiments, for each
reconstruction, we selected a labeled (i.e., newly assembled)
1235Figure 3 Immunoelectron microscopic analyses on the axons of cultured sympathetic neurons . The YL 1/2 antibody against tyrosinated
a-tubulinwas used to differentiate newly assemblyMT polymerfrom stable polymer (see text) . In control axons (a), roughly equal levels
of polymer are labeled and unlabeled . After 6 h of treatment with 10 jig/ml nocodazole (b), all of theMT profiles are unlabeled, and
appear to be reduced in length relative to the controls . After 1 min of recovery (c), profiles of labeled polymer, roughly similar in length
to the unlabeled profiles, are present. After 5 and 30 min of recovery (d and e, respectively), the unlabeled profiles show no apparent
change,butthe levels oflabeled polymerhave increased substantially. After24 hofrecovery (f), thelevels oflabeledandunlabeledpolymer
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Figure 4. Levels ofMT mass in experimentally manipulated axons
relative to controls. The lengths of newly assembled and stable
polymer were summed separately over an area spanning five open
spaces on a 200-mesh transmission EM grid . The white areas of
the graph indicate stable polymer, while the hatched areas indicate
newly assembled polymer (distinguished electron microscopically
by the specific staining of the latter for tyrosinated a-tubulin) . In
control axons, half of the total MT mass was of each type . After
6 h of nocodazole treatment at 10 gg/ml, only 5% of the total MT
mass remained, and all of this was unlabeled (i.e ., stable) . After
1, 5, and 30 min of recovery, the levels of stable polymer were un-
changed, but the levels of new polymer increased progressively. At
24 h of recovery, levels of stable and new polymer were indistin-
guishable from controls .
MT profile in the center-most section of our series of 15, and
followed it out in both directions through the serial sections
to determine its association with stable polymer or other
potential nucleating structures (see Materials and Methods) .
In 25 such profiles examined, 24 were found to be continu-
ous with the plus ends of stable polymer (Fig . 5 a ; see also
3 c), none were continuous with the minus end of stable
polymer, none were found unassociated with stable polymer,
and one was ambiguous because of folds in the epon/butvar
(Table I) . In a second set of experiments, for each recon-
struction, theMT profile chosen as a starting point was unla-
beled (i.e ., a stable MT) . In 25 such profiles, none were
continuous with the plus end ofnew polymer, 19 were con-
tinuous with the minus end ofnew polymer, 5 were not con-
tinuous with new polymer, and 1 was ambiguous (Table
I) . The average length ofnew polymer after 1 min was 3.5
t 1 pm . (Although this figure is probably an underestimate
in that our method biases against the selection of the longer
MT profiles [see Materials and Methods], it is interesting to
note that remarkably similar figures have been reported for
the rate ofMT assembly in nonneuronal cells [Schulze and
Kirschner, 1986], and for the rate ofMT-dependent regrowth
of amputated axon segments [Baas and Heidemann, 1986]) .
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Figure S. Serial reconstructions of axonal MTs in neuron cultures
treated for 6 h with 10 gg/ml nocodazole followed by recovery for
1 min (a) or 5 min (b) . New polymer, distinguished electron micro-
scopicallyby its staining for tyrosinated a-tubulin, is indicated with
surrounding black dots . In all cases, new polymer assembled di-
rectly from the plus ends of stable polymer. Open space in b repre-
sents 8.5 )Am oflabeled polymer. See text for more details, and Ta-
ble I for quantitative data . Width of MTs on reconstructions is not
to scale . Bar, 3 /Am.
Collectively, these results suggest that all new polymer as-
sembles directly from the plus ends of stable MTs in the
axon. The stableMT§ from which no assembly occurred pre-
sumably represent either a subpopulation of stable MT§ in
the axon which are not assembly competent, or perhaps
more likely, stable MTh that are no different from the rest,
but from which no assembly had yet occurred at this short
recovery time .
A possibility worth considering is that the plus ends ofsta-
bleMTS. are thepreferred, but not exclusive, sites ofnewMT
assembly in the axon . That is, ifwe had extended the recov-
ery time somewhat longer, new polymer may have arisen in-
dependently of these nucleating structures. To test this hy-
pothesis,weperformed serial reconstruction studies at 5 min
of recovery, after which substantial MT reassembly had oc-
curred (with polymer levels reaching 20-25% ofcontrol lev-
els ; Figs . 3 d and 4) . These experiments were more difficult
in that, because of the greater lengths of new polymer, the
vast majority of MTs we pursued did not terminate within
our 15 sections, and hence had to be discarded from our data
(see Materials and Methods). Despite this difficulty, we were
able to locate three labeled profiles and three unlabeled
profiles that were usable for our analyses . The average length
ofnew polymer in these six MTh was 17.2 f 2 /Am, almost
exactly five times the length at 1 min of recovery. Consistent
with our results at 1 min of recovery, all three of the labeled
profiles (i.e., new polymer) were continuous with the plus
ends of stable polymer, and all three ofthe unlabeled profiles
(i.e., stable polymer) were continuous with the minus ends
of new polymer (Fig. 5 b and Table I) .
Collectively, the results ofour serial reconstructions indi-
cate that all new MT assembly in the axon occurs from the
plus ends ofstable polymer. Nonew polymer arises indepen-
dently ofthe stable polymer, indicating that no self-assembly
ofMTs occurs in the axon, nor do any MT nucleating struc-
tures exist in the axon other than the plus ends of stableMTs.
Basedon these observations, we conclude that the plus ends
are indistinguishable from controls. Arrows mark MT profiles in which a newly assembled domain can be visualized in direct continuity
with the plus end of a stable domain (curved arrow marks a somewhat ambiguous example of the same) . Plus ends ofMTh are oriented
to the right of the panels. See text for more details and Fig . 4 for quantitative data . Bar, 0.2 gm .Table I . Summary ofDatafrom Serial Reconstruction
ofAxonal MTs
MTPolarityAnalyses
MTs in cultures recovered for 1 or 5 min from treatment with 10 Ag/ml
nocodazole for 6 h were serially reconstructed as described in the text (see
Materials and Methods and Results) . In one set of experiments, a profile la-
beled for tyrosinated tubulin (i .e ., newly assembled polymer) was selected as
a starting point, whereas in a second set of experiments, an unlabeled profile
(i.e ., stable polymer) was selected as a starting point. In all cases, newly as-
sembled polymer arose in direct continuity with the plus ends ofstablepolymer
(see text for more details ; see also Fig . 5) .
* Serial reconstructions were based on the initial selection of a labeled MT
profile. Therefore, the "opposite type" refers to unlabeled polymer .
t Serial reconstructions were based on the initial selection ofan unlabeledMT
profile . Therefore, the "opposite type" refers to labeled polymer .
of stable MTs are the exclusiveMT nucleating structures in
the axon .
Before closing, it is important to consider the possibility that
the short MT§ remaining after nocodazole treatment may
have shiftedorientation in the axon, such that theminusends
of some MT§ in our experimental axons may have been
directed away from the cell body. Ifsuch an inversionhasoc-
curred, then the conclusion drawn from our serial recon-
struction studieswith respectto MT polarity is incorrect. To
test this possibility, we analyzed MT polarity orientation in
control and experimentally manipulated cultures. For these
analyses, we used the standard "hook" protocol, in which
neurons are lysed in a special MT assembly buffer contain-
ing exogenous tubulin . The exogenous tubulin adds onto ex-
Figure 6 . Analyses onMT polarity orientation intheaxons of cultured sympathetic neurons using the standard "hook" technique (see Mate-
rials and Methods) . As viewed from thevantage point of the growth cone, clockwisehooks on theMTs indicate that the plus ends of the
MTs are distal to the cell body, and counterclockwise hooks indicate the opposite . In the axons of control cultures (a), cultures treated
with 10 ug/ml nocodazole for 6 h (b), and cultures recovered from such treatment for 1 (not shown), 5 (c), and 30 (d) min, and 24 h
(not shown), hooks were predominantly clockwise, indicating uniform MT polarity orientation, plus ends distal to the cell body. Bar,
0.1 AM .
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Table 11. MT Polarity Orientation in Control and
Experimental Axons
MT polarity orientation was determined using the standard "hook" procedure
(see Baas et al ., 1989 and Materials and Methods) . In this procedure, neurons
are lysed in a specialMT assembly buffer in the presence of exogenous brain
tubulin . The exogenous tubulin adds onto existing MTs in the form of lateral
protofilament sheets that appear on the MTs as hooked appendages when
viewed in cross section electron microscopically . A clockwise hook indicates
that the plus end of the MT is directed toward the observer, while a counter-
clockwise hook indicates that the minus end of the MT is directed toward the
observer .MT polarity orientation was analyzed in control axons, as well as ax-
ons treated for6h with 10 gg/ml nocodazole, and axons recovered from such
treatment for 1, 5, and30 min, and 24 h . In all of these situations, hooks were
predominantly clockwise as viewed from the growth cone, indicating uniform
MT polarity orientation, plus ends distal to the cell body . CW, microtubules
with clockwise hooks as viewed from the tip of the axon looking toward the
cell body ; CCW, micrombules with counterclockwise hooks as viewed from
same ; AMB, microtubules with ambiguous hooks ; UHK, microubules with no
hooks ; HK, microtubules with hooks .
* Indicates sum of all MTs for all 50 axons of each type analyzed .
t Mean f SD for all 50 axons scored .
istingMT§ as lateralsheets that appear as "hooks"on the MTs
when viewed in cross section. A clockwise hook indicates
that the plus end of the MT is directed toward the observer,
while a counterclockwise hook indicates the opposite . For
thepresent study, we analyzedMT polarity orientationin the
axons of control cultures, cultures treated with 10 pg/ml
nocodazole for 6 h, and cultures permitted to recover from
such drug treatment for 1, 5, and 30 min, and 24 h. In all
of these situations, 94-96% of thehooks were clockwise as
viewed from thegrowth cone, indicating uniformMT polar-
ity orientation, plus ends distal to the cell body (see Fig. 6
andlhble II) . These resultsindicate that no inversionofMT§
occurred during nocodazole treatment or recovery, are con-
sistent with the conclusion that no haphazardMT assembly
occurs within theaxon, and validate the strong conclusions
derived from our serial reconstruction studies.
It should be mentionedthat ourMT polarity results differ
Total MT
examined
Number at
[+] end of
opposite
type
Number at
[-] end of
opposite
type
Number not
continuous
with other
type Ambiguous
1 min
recovery* 25 24 0 0 1
1 min
recovery$ 25 0 19 5 1
5 min
recovery* 3 3 0 0 0
5 min
recoveryt 3 0 3 0 0
CW* CCW* AMB* UHK* % HK$ % CWt
Control 500 21 35 115 83 t 3 96 t 3
6 h nocodazole 54 3 7 11 85 ± 5 95 ± 5
1 min recovery 75 4 9 13 88 ± 5 95 ± 4
5 min recovery 152 10 14 32 84 f 6 94 t 2
30 min recovery 488 21 22 94 85 f 7 96 f 3
24 h recovery 522 25 44 136 81 f 6 95 f 6somewhat from those of Heidemann et al. (1984), who per-
formed the original MT polarity work of this kind on short
segments of sympathetic axons isolated from the cat. These
authors found that the proportion ofplus-end-distal MTs was
somewhat lowerafter recovery from boutsof MT disassem-
bly (at most 83% clockwise hooks), suggesting that either
some de novo assembly occurred, or that some ofthe stable
MTs did, in fact, change orientation. Also in contrast with
our results, Heidemann et al. observed an extremely rapid
reassembly of MT polymer, the levels of which exceeded
control levels after only 5 min of recovery. The reasons for
these differing results are unclear. However, in light of the
consistency ofour polarity and immunoelectron microscopic
results, and the noninvasive nature of our experimental sys-
tem, we have confidence in the strong conclusions that can
be drawn from our results. One possibility is that the ex-
perimental conditions of Heidemann et al., who performed
all of their manipulations on dissected pieces of tissue,
may have introduced some nonphysiological factors that
had some effect on MT assembly and organization in their
samples.
Discussion
In the present study, we have sought to determine the distri-
bution and identity of the MT nucleating structures in the
axon. Our strategy was to visualize the nucleating structures
by their capacity to initiate MT reassembly during recovery
from nocodazole treatment, a strategy previously used to
identify MT nucleating structures in nonneuronal cells (De
Brabander et al., 1977, 1980; Brinkley, 1985; Gunderson et
al., 1987; Bulinski et al., 1988) . New polymer was distin-
guished from stable polymer by the preferential staining of
the former for tyrosinated a-tubulin (Baas and Black, 1990;
Baas et al., 1991b). This permitted us to directly test the
long-standing hypothesis that stable MTs serve as MT
nucleating structures in the axon (see introduction). Our
results at the immunofluorescence level indicate that MT
nucleating structures have a widespread (but uneven) distri-
bution along the length of the axon, with the exception of its
most distal region contiguous with the growth cone, which
contains no nucleating structures. Our results at the immu-
noelectron microscopic level reveal the identity of these
nucleating structures. These data indicate that the plus ends
of stable MTs in the axon are assembly competent, and
moreover, that all MT assembly in the axon occurs via elon-
gation from these plus ends. No assembly occurs from the
minus ends of stable MTs, nor does any assembly occur in-
dependently ofthe stable MTs. Thus the plus ends of stable
MTs are the exclusive MT nucleating structures in the axon .
These results complement the results of previous studies,
and have important implications for the mechanisms by
which the MT array of the axon is established and main-
tained. For example, the conclusionthat all MT assembly in
the axon occurs via elongation from stable MTs is supported
by previous data indicating that no MT reassembly can occur
if axon segments are experimentally depleted of stable as
well as labile MT polymer (Baas and Heidemann, 1986) .
The present results are also consistent with our previous data
suggesting that most or all MTs in the axon consistof a labile
domain situated at the plus end of a stable domain (Baas and
Black, 1990), and with studies demonstrating that when bi-
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otinylated tubulin is microinjected into PC12 cells, it incor-
porates specifically atthe plus ends of MTs in theiraxon-like
neurites (Okabe and Hirokawa, 1988). Finally, our results
provide a simple explanation for the mechanism by which the
uniform polarity orientation of MTs is maintained in the
axon. Because all new assembly occurs from the plus ends
ofpreexisting MTs, the new polymer will share the plus-end-
distal polarity orientation already established for the stable
polymer. In this manner, the specialized assembly properties
ofaxonal MB can account for the maintenance of their orga-
nization.
Interestingly, assembly competence is a property not
generally shared by stable MTs in other cell types (Webster
et al ., 1987). In nonneuronal cells, MTs are thought to be
stabilized by end caps, the presence of which blocks disas-
sembly, but also blocks new assembly from the ends (Web-
ster et al., 1987; Khawaja et al., 1988) . In the axon, the as-
sembly competence of stable MB at theirplus ends indicates
that these MT§ are stabilized by a mechanism other than end
caps, presumably the binding ofaccessory proteins alongthe
length of the MT. Although the identity of these factors is
unknown, principal candidates include the microtubule-
associated proteins tau and STOP Tau is an axon-enriched
protein which has been shown to promote MT assembly and
nucleation in the test tube (Bre and Karsenti, 1990), and to
increase the levels of stable MTs when microinjected into
living cells (Drubin and Kirschner, 1986). In addition, ex-
pression of tau in certain nonneuronal cells causes them to
develop processes with an axon-like MT organization (Baas
et al., 1991x). STOP, a protein abundant in neuronal tissue,
has been shown to markedly enhance the stability of MTs in
the test tube (Margolis et al., 1986), and to preferentially as-
sociate with the stable MD ofthe mitotic spindle in neuronal
precursor cells (Margolis et al., 1990) . The lack ofassembly
ofthe stable MTs at their minus ends suggests that the minus
end may be capped by an as yet unidentified structure. Alter-
natively, there might be factors in the axoplasm that strongly
support plus-end assembly and/or suppress minus-end as-
sembly. Precedent for such factors exists in Xenopus eggs
(Gard and Kirschner, 1987) and surf clam oocytes (Supre-
nant, 1991). Current efforts are aimed at elucidating the po-
tential roles that factors such as those discussed here may
play in determining the stability and assembly properties of
MTs in the axon.
The results of our studies raise another interesting and
quite fundamental question concerning the mechanisms by
which the axonal MT array is elaborated . Because of the
great length that axonscan grow, the length ofany MT within
the axon will generally be short relative to that of the axon
(Bray and Bunge, 1981; Bukita and Ishikawa, 1981). Thus
axon growth clearly requires the generation of new MTs, as
well as the elongation of existing MTs. If no new MTs are
generated within the axon itself, as our data indicate, where
do these new MTs arise? Previous speculations pointed to the
distal region ofthe axon behind the growth cone as a poten-
tial site for the generation of new MTs (Mitchison and
Kirschner, 1988) . Our data are inconsistent with this notion,
and by the process of elimination, point to the cell body as
the only potential source of new MTs for the axon . If this
reasoning is correct, then MTs destined for the axon must
first arise in the cell body, and then move into the axon by
an active transport mechanism. It is intriguing to contem-
1239plate that such movement, if it exists, may be unidirectional
with respect to the polarity of the MT, thereby establishing
the uniform polarity orientation of the axon (Baas et al.,
1991x).
The concept of MT nucleation in the cell body followed
by transport into the axon is a long-standing hypothesis
(Black and Lasek, 1980; Lasek, 1982) that has fallen into
disfavor in recent years because ofthe demonstration oflocal
MT assembly within the axon itself (Bamburg et al., 1986;
Baas and Heidemann, 1986; Baas et al., 1987; Okabe and
Hirokawa, 1988, 1990; Robson and Burgoyne, 1988 ; Lim et
al., 1989,1990; Keith, 1990; Baas and Black, 1990; Arregui
et al., 1991) . However, in its truest form, the model ofLasek
and collaborators accounts for both polymer movement and
elongation within the axon (for more details, see Lasek,
1988) . Our data support this view, suggesting that axonal
MTs originate in the cell body, but are elongated principally
within the axon. If this is correct, attention shifts to identify-
ing the structures in the cell body that nucleate MTs for the
axon. One possibility is that MTs destined for the axon are
nucleatedby atraditional MTnucleating structure such as the
centrosome, after which they detach from this structure, and
then move into the axon. In support of this possibility, there
is some precedent for MT detachment from the centrosome
in other cell types (McBeath and Fujiwara, 1990). Alterna-
tively, however, the MT nucleating capacity of the centro-
some may itself become dissociated from that structure
during neuronal development, and take on a widespread dis-
tribution throughout the somatodendritic compartment of
the neuron (Baas et al., 1989) . In either view, the notion of
MT movement into and along the axon is essential. The con-
cept of MT movement and elongation occurring in concert
with one another has recently garnered very elegant experi-
mental support in studies tracing the progress of photoacti-
vated bands of tubulin in the axon (for details see Reinsch
et al., 1991).
In conclusion, our studies have provided direct informa-
tion on the identity and distribution of MT nucleating struc-
tures in the axon. The plus ends of stable MTs are the exclu-
sive nucleating structures for MTs in the axon, and they have
a widespread distribution along the axods length . As usual,
the resolution of this issue has introduced a myriad of new
questions. We have provided some discussion with regard to
these questions, and our future efforts with be aimed at test-
ing the merits of our speculations.
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